Among the pharmaco-resistant mechanisms to the alkylating agent (Temozolomide), the most common one found in GBM is O6-methylguanine-methyltransferase (MGMT), a specific DNA repair protein, whose expression is variable due to the acquired methylation of the gene promoter during gliomagenesis. The gene discussed is XRCC6P5; the disease is glioblastoma.